References
Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77(12):2622–9.
Cooksley TJ, Haji-Michael P. Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2011;9:169.
Foster JM, Sleightholm R, Patel A, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermicintraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847.
Webb C, Day R, Velazco CS, et al. Implementation of an enhanced recovery after surgery (ERAS) program is associated with improved outcomes in patients undergoing cytoreductive surgery and hyperthermicintraperitoneal chemotherapy. Ann Surg Oncol. 2020;27(1):303–12.
Chicago Consensus Working Group. The chicago consensus on peritoneal surface malignancies: standards. Ann Surg Oncol. 2020;27(6):1743–52.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Fadi S. Dahdaleh, Bradley White, and George I. Salti declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dahdaleh, F.S., White, B. & Salti, G.I. ASO Author Reflections: Enhanced Recovery After CRS/HIPEC—An Opportunity to Meet Quality Standards. Ann Surg Oncol 28, 5273–5274 (2021). https://doi.org/10.1245/s10434-020-09529-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09529-9